C

콜마비앤에이치

200130KOSDAQ기초 의약물질 제조업

43.5 / 100

Reference Date: 2026-04-13

Financial Score16.0 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Slightly down 3.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Colmar B&H is a R&D-focused company specializing in developing natural-based materials for health functional foods and cosmetics, producing and selling them via ODM/OEM. In 2025, its revenue reached 574,885 million won, with health functional foods (55.1%) and cosmetics (41.7%) as major revenue sources, exporting to 26 countries including China, the U.S., and Japan.

Number of Employees

468people

Average Salary

66.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 33.454.0Point
PBR
0.95Industry Average 2.037.0Point

Half of industry avg (excellent)

ROE
-6.03Industry Average -4.293.5Point

In line with industry avg

Debt Ratio
28.25Industry Average 6.610.0Point

4.3x industry avg (risky)

Trend 2023~20251.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼0.2% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼5.2% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 1.0% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 0Neutral 2Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 11,470Won52-week high 17,70052-week low 10,850
1-month return2.0Point

1m -3.21% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral대표이사변경2026-03-31
  • Neutral정기주주총회결과2026-03-31
  • Neutral[기재정정]영업양도결정(종속회사의주요경영사항)2026-03-26
  • Neutral[기재정정]타법인주식및출자증권처분결정2026-03-25
  • Neutral사업보고서 (2025.12)2026-03-17